Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Receivables (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Change in Receivables data on record, last reported at -$1.4 million in Q1 2013.

  • For Q1 2013, Change in Receivables fell 1413.59% year-over-year to -$1.4 million; the TTM value through Mar 2013 reached -$411000.0, down 350.61%, while the annual FY2025 figure was -$434000.0, 288.7% down from the prior year.
  • Change in Receivables reached -$1.4 million in Q1 2013 per SNOA's latest filing, down from $237000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.2 million in Q2 2012 and bottomed at -$1.4 million in Q1 2013.
  • Average Change in Receivables over 4 years is -$72750.0, with a median of $22500.0 recorded in 2010.
  • Peak YoY movement for Change in Receivables: soared 2488.24% in 2012, then tumbled 1413.59% in 2013.
  • A 4-year view of Change in Receivables shows it stood at -$497000.0 in 2010, then skyrocketed by 79.48% to -$102000.0 in 2011, then surged by 332.35% to $237000.0 in 2012, then tumbled by 670.89% to -$1.4 million in 2013.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$1.4 million in Q1 2013, $237000.0 in Q4 2012, and -$513000.0 in Q3 2012.